{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T20:49:09Z","timestamp":1783111749891,"version":"3.54.6"},"reference-count":50,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T00:00:00Z","timestamp":1724630400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Basic Clin Pharma Tox"],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Multiple myeloma (MM) is an incurable cancer in the bone marrow. The treatment of MM has developed significantly during the last 20\u2009years, which has resulted in increased survival. Daratumumab is the first CD38 antibody approved for the treatment of MM. It has improved the treatment of MM even further. This is an evaluation of the modes of action of daratumumab and a description of the development of resistance with a focus on inhibitory checkpoint receptors on CD8<jats:sup>+<\/jats:sup> T\u2010cells, complement activation and extracellular vesicles.<\/jats:p>","DOI":"10.1111\/bcpt.14054","type":"journal-article","created":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T07:19:26Z","timestamp":1724656766000},"page":"401-408","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Mechanisms of resistance to daratumumab in patients with multiple myeloma"],"prefix":"10.1111","volume":"135","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4494-9034","authenticated-orcid":false,"given":"Katrine Fladeland","family":"Iversen","sequence":"first","affiliation":[{"name":"Institute of Regional Health Science, University of Southern Denmark, and Department of Internal Medicine, Section of Hematology Lillebaelt Hospital, University Hospital of Southern Denmark  Vejle Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,8,26]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102007\u201010\u2010078022"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.2991\/chi.d.190805.002"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.4065\/79.7.867"},{"key":"e_1_2_9_5_1","unstructured":"GregersenH Silkj\u00e6rT KristensenIB.Prim\u00e6rbehandling af myelomatosepatienter der er kandidater til h\u00f8jdosis kemoterapi2023. doi:https:\/\/myeloma.hematology.dk\/index.php\/vejledninger\u2010dmsg\/440\u2010primaerbehandling\u2010af\u2010myelomatosepatienter\u2010der\u2010er\u2010kandidater\u2010til\u2010hojdosis\u2010kemoterapi\u2010pdf\/file"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1817249"},{"key":"e_1_2_9_7_1","unstructured":"KlostergaardA VaseM.Relapsbehandling af myelomatose.2022 doi:https:\/\/myeloma.hematology.dk\/index.php\/vejledninger-dmsg\/441-relapsbehandling-af-myelomatose-1\/file"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102017\u201006\u2010740944"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1003032"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2015.1007813"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V124.21.3474.3474"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102015\u201012\u2010687749"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2018.1486948"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008\u20105472.CAN\u201018\u20100773"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/s1470\u20102045(21)00466\u20106"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.22.00940"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0258487"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102010\u201010\u2010299487"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.4161\/mabs.29670"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1172\/jci90962"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022\u20101759(81)90107\u20101"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102016\u201003\u2010703439"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.123"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021005220"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102017\u201003\u2010770776"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102021\u2010152070"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102022\u2010159116"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102019\u2010125788"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.2119\/molmed.2016.00198"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045\u2010016\u20100345\u20103"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15888"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102018\u201001\u2010825265"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13102452"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s44228\u2010022\u201000013\u20107"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.79"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V128.22.2102.2102"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102018\u201099\u2010117531"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375\u2010020\u20100855\u20104"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2017006866"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375\u2010020\u20100810\u20104"},{"key":"e_1_2_9_41_1","doi-asserted-by":"crossref","unstructured":"ZicchedduB GiannottaC D'AgostinoM et al.Genomic and immune determinants of resistance to anti\u2010CD38 monoclonal antibody\u2010based therapy in relapsed refractory multiple myeloma. medRxiv 2023.10.1101\/2023.12.04.23299287","DOI":"10.1101\/2023.12.04.23299287"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1097\/hs9.0000000000000881"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1704286"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13277\u2010015\u20103741\u20103"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2018.07.003"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102018\u201099\u2010115730"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.22773"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1102855108"},{"key":"e_1_2_9_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17329"},{"key":"e_1_2_9_50_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells11213365"},{"key":"e_1_2_9_51_1","doi-asserted-by":"crossref","unstructured":"IversenKF.Resistance to daratumumab in patients with multiple myeloma.2024.Syddansk Universitet (sdu.dk).","DOI":"10.22541\/au.171345600.04580861\/v1"}],"container-title":["Basic &amp; Clinical Pharmacology &amp; Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bcpt.14054","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T04:31:53Z","timestamp":1726720313000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/bcpt.14054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,26]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["10.1111\/bcpt.14054"],"URL":"https:\/\/doi.org\/10.1111\/bcpt.14054","archive":["Portico"],"relation":{},"ISSN":["1742-7835","1742-7843"],"issn-type":[{"value":"1742-7835","type":"print"},{"value":"1742-7843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,26]]},"assertion":[{"value":"2024-01-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}